FIA
NVIV

FNY Investment Advisers’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

FNY Investment Advisers’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$1K – 1235
2018
Q3 		$1K Buy
+1
New +$1.47K ﹤0.01% 849

Other funds holding NVIV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FNY Investment Advisers's NVIV Position: Q4 2018 in Review

FNY Investment Advisers sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q4 2018, closing a stake of 1 share — an estimated $1K sold.

FNY Investment Advisers first reported a position in NVIV in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 15 funds tracked by Wall St. Rank hold NVIV as of Q4 2018.

  • FNY Investment Advisers reported no remaining InVivo Therapeutics Holdings Corp position as of Q4 2018 after selling out during the quarter.
  • FNY Investment Advisers sold 1 InVivo Therapeutics Holdings Corp share in Q4 2018, an estimated $1K.
  • FNY Investment Advisers first reported a position in InVivo Therapeutics Holdings Corp in Q3 2018 and held it in 1 quarter.
  • FNY Investment Advisers's InVivo Therapeutics Holdings Corp position peaked at $1K in Q3 2018.
  • 15 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.